When was Hot Screen founded?

Hot Screen was founded in 1996.

Where is Hot Screen located?

Hot Screen is headquartered in Reutlingen, Germany.

Who is the current CEO of Hot Screen?

Manfred Schmolz of Hot Screen. They have also founded 1 company.

How many employees does Hot Screen have?

As of Dec 31, 2020, the latest employee count at Hot Screen is 22.

Is Hot Screen a funded company?

Hot Screen is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Hot Screen rank among its competitors?

Hot Screen ranks 39th amongst 69 active competitors, of which 18 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Metrion Biosciences, which secured $4.7M in Dec, 2023.

Who are the top competitors of Hot Screen?

Hot Screen's top competitors include Metrion Biosciences, Anabios and Global Access Dx. Among them, Metrion Biosciences secured the most recent funding round in December, 2023.

Hot Screen - 2026 Company Profile, Team & Competitors

Hot Screen is an unfunded company based in Reutlingen (Germany), founded in 1996 by Manfred Schmolz. It operates as a Provides specialized cell based assays to pharma, food supplement, and cosmetics industries. Hot Screen has not raised any funding yet. The company has 69 active competitors, including 18 funded and 9 that have exited. Its top competitors include companies like Metrion Biosciences, Anabios and Global Access Dx.

Company Details

Hot Screen, founded in 1996 as EDI, merged with Rule-based medicine in 2007 and recently became HOT Screen GmbH due to an MBO(Management buyout) from Myriad-RBM. It assists pharma, food supplement, and cosmetics industries by providing platforms which include customized cell culture, whole blood culture, and human organoleptic test (HOT) systems. HOT Co-Culture and the TruCulture Systems are specialized assays which closely mimic complex in-vivo organ systems (Lung, skin, joint, veins). It is also involved in contract screening of drugs, nutraceuticals, food supplements, probiotics, cosmetics, and implant materials.

Website: edigmbh.de
Phone Number: +49 **********
Part Of

Key Metrics

Founded Year

1996

Location

Reutlingen, Germany

Stage

Unfunded

Ranked

39^th among 69 active competitors

Employee Count

22 as on Dec 31, 2020

Similar Companies

Metrion Biosciences & 76 more

View Hot Screen's full profile

Hot Screen is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
HOT Screen GmbH CIN: HRB748203 , Germany, Active	Mar 11, 2014	-	22 (As on Dec 31, 2020)

Hot Screen has not raised any funding rounds yet.

The founders of Hot Screen is Manfred Schmolz. Manfred Schmolz is the CEO of Hot Screen.

Here are the details of Hot Screen's key team members:

Manfred Schmolz: Co-Founder & CEO of Hot Screen.

View details of Hot Screen's Founder profiles and Board Members

Hot Screen's employee count trend

Hot Screen has 22 employees as of Dec 20. The total employee count is the same as what it was in Dec 19. Here is Hot Screen's employee count trend over the years:

Uncover Hot Screen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Hot Screen include Metrion Biosciences, Anabios and Global Access Dx. Here is the list of Top 10 competitors of Hot Screen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Metrion Biosciences 2015, Cambridge (United Kingdom), Series B	CRO specializing in ion channel screening, cardiac safety profiling and drug discovery services	$8.44M	Gresham House Ventures, o2h ventures & 23 others	47/100
2nd	Anabios 2009, San Diego (United States), Series B	Human tissue and cell provider accelerating drug discovery and development	$24.8M	Tech Coast Angels, Principia SGR & 8 others	45/100
3rd	Global Access Dx 2003, Thurleigh (United Kingdom), Funding Raised	Developer of rapid diagnostic tests and lateral flow technologies	-	-	43/100
4th	Clyde Biosciences 2012, Holytown (United Kingdom), Series A	Boutique Contract Research Organisation for cardiac safety testing	$3.5M	Epidarex Capital, Scottish Enterprise & 3 others	42/100
5th	Jiva Sciences 2015, Bengaluru (India), Funding Raised	Provides research process outsourcing	-	IKP Knowledge Park, KITVEN & 2 others	39/100
6th	Antibody Analytics 2015, Lanark (United Kingdom), Series A	Offers antibody analytics services	-	NorthEdge	39/100
7th	Rules-Based Medicine 2002, Austin (United States), Acquired	Multiplexed biomarker diagnostics.	$25M	Cross Creek, The Stephens Group	38/100
8th	Apconix 2015, Alderley Edge (United Kingdom), Unfunded	Preclinical CRO offering integrated services for toxicology and ion channel studies	-	-	38/100
9th	Optivia Biotechnology 2007, San Francisco (United States), Acquired	CRO offering transporter screening services and solutions for DDI, DMPK, safety and pharmacology	-	HHS	36/100
10th	Pelago Bioscience 2013, Solna (Sweden), Seed	Assay services for use in the determination and quantification of drug-target interactions	-	Impilo, Europa & 1 others	35/100
39th	Hot Screen 1996, Reutlingen (Germany), Unfunded	Provides specialized cell based assays to pharma, food supplement, and cosmetics industries	-	-	24/100